pancreatic-cancer

Documents about pancreatic-cancer

• Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms#888960ClinicalTrials.gov
• A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies#901932ClinicalTrials.gov
• Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles#870302ClinicalTrials.gov
• A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab#899340ClinicalTrials.gov
• EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice#911302ClinicalTrials.gov
• Mechanisms of Synergy Between Nanosecond Pulsed Electric Field (nsPEF) and Cold Atmospheric Pressure Plasma Discharge (CAP) in Pancreatic Cancer: The Role of ROS-Mediated Oxidative Stress and Apoptosis#434501ODU Digital Commons
• A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer#839038ClinicalTrials.gov
• 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors#881267ClinicalTrials.gov
• A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)#887804ClinicalTrials.gov
• ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort#801877ClinicalTrials.gov
• Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer#891532ClinicalTrials.gov
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing#125827ClinicalTrials.gov
• Cascade Therapy With Doxorubicin and Survivin-Targeted Tailored Nanoparticles: an Effective Alternative for Sensitization of Cancer Cells To Chemotherapy#681779İzmir Yüksek Teknoloji Enstitüsü
• Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors#802745ClinicalTrials.gov
• Self-Assembled Nucleolipid G-Quadruplexes Act as Multitarget Decoys for Oncogene Suppression in Pancreatic Cancer#152637bioRxiv / medRxiv
• Stromal Cell–Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer#187185Zenodo (CERN)
• Stress-induced CXCL13 regulates pancreatic exocrine homeostasis, age-related chronic inflammation, and cancer progression#235498Kyoto University Research Information Repository
• Gemcitabine-Induced neutrophil extracellular traps via interleukin-8-CXCR1/2 pathway promote chemoresistance in pancreatic cancer#292635OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• A HRH1-YAP1 feedback loop drives pancreatic cancer progression and predicts therapeutic response.#330730NCBI PubMed Central
• Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy#414479ClinicalTrials.gov
• CAFs shape the immunosuppressive microenvironment of pancreatic cancer through the Lin28b-STING Axis.#659685NCBI PubMed Central
• Immunomodulatory impact of PTPN11/SHP2-based vertical RAS-MAPK pathway inhibition in pancreatic cancer#784079Deutsche Nationalbibliothek
• Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer#842241ClinicalTrials.gov
• Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)#850084ClinicalTrials.gov
• Exercise to Improve Outcomes in Pancreatic Cancer#893769ClinicalTrials.gov
• Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV#906271ClinicalTrials.gov
• FAPI PET Imaging - An Exploratory Study#870195ClinicalTrials.gov
• The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors#874757ClinicalTrials.gov
• Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma#902025ClinicalTrials.gov
• Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors#833985ClinicalTrials.gov
• IDENTIFYING WNT-REGULATED SMALL ORF-ENCODED PEPTIDES (SEPS) IN AN IN VIVO MOUSE MODEL OF PANCREATIC CANCER#330633ScholarBank@NUS
• OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC#442103ClinicalTrials.gov
• Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer#852553ClinicalTrials.gov
• Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer#867120ClinicalTrials.gov
• Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II#904104ClinicalTrials.gov
• Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy#801261ClinicalTrials.gov
• Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation#861863ClinicalTrials.gov
• A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors#830273ClinicalTrials.gov
• Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program#900360ClinicalTrials.gov
• A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer#349975ClinicalTrials.gov
• Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy#802461ClinicalTrials.gov
• A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors#861794ClinicalTrials.gov
• Efficacy of NPWT in Reducing the Incidence of Wound Infection After Pancreatic Surgery#888764ClinicalTrials.gov
• Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy#837847ClinicalTrials.gov
• Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors#865069ClinicalTrials.gov
• Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors#879788ClinicalTrials.gov
• A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors#18576ClinicalTrials.gov
• Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: Implications for intervention#153472PMC Full-Text (OAI)
• Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas#174853ClinicalTrials.gov
• Pan-cancer characterization of HMGA1 reveals its oncogenic role in tumor microenvironment and stemness: functional validation in pancreatic cancer migration and invasion.#685688NCBI PubMed Central